The
cell walls of the genus Rhodococcus including
the pathogenic bacterium Rhodococcus equi (R. equi) and biotechnologically important bacterium Rhodococcus opacus (R. opacus) contain
an abundant peptidolipid (or termed lipopeptide)
family whose structures have not been reported previously. Here, we
describe a linear ion-trap multiple-stage mass spectrometric (LIT
MSn) approach with high resolution mass spectrometry (HRMS),
in conjunction with NMR spectroscopy, chemical reactions, and GC/MS
analysis to define the structures of these compounds. We employed
LIT MS
n
(n = 2–8)
on the [M + Na]+ ion species to establish the peptide sequence,
the identity of the fatty acyl substituent, and its location within
the molecule, while NMR spectroscopy and GC/MS were used to recognize
the Leu and Ile moieties. The major new lipopeptide found in R. opacus is defined as C17H35CH(OH)CH2CO-NHLeu-Ser-Leu-Ile-Thr-Ile-PheCOOH, where a β-OH fatty
acyl (C18–C22) substituent is attached
to the N-terminal of the LSLITIF peptide chain via a NH–CO
bond. By contrast, the main peptidolipids found in R. equi belong to the cyclopeptidolipid family, which possesses the same
peptide sequence and lipid chain, but the β-OH group of the
fatty acyl moiety and the C-terminus of the peptide (i.e., the −COOH)
are cyclized by an ester bond formation to a lactone, with a structure
similar to iturin-A (Biochemistry19781739923996). The
antibiotic activity test of these new lipids did not reveal an activity
against any of seven microorganisms tested.